Insider · CIK 0001398595

Fitzpatrick Alexander A

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001398595

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-12	SPRYARS Pharmaceuticals, Inc.S Sale	Chief Legal Officer	SSale	−3,355 sh	$10.00	−$33.6K	90,910
2026-01-02	SPRYARS Pharmaceuticals, Inc. · Stock option (right to buy)A Award	Chief Legal Officer	AAward	+240K sh	—	—	240,000
2025-05-20	SPRYARS Pharmaceuticals, Inc.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+100K sh	$5.58	+$558K	192,582
2025-05-20	SPRYARS Pharmaceuticals, Inc.S Sale	Chief Legal Officer	SSale	−103K sh	$14.10	−$1.45M	89,613
2025-05-20	SPRYARS Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−100K sh	—	—	200,000
2025-01-02	SPRYARS Pharmaceuticals, Inc. · Stock option (right to buy)A Award	Chief Legal Officer	AAward	+152K sh	—	—	152,300
2024-01-02	SPRYARS Pharmaceuticals, Inc. · Stock option (right to buy)A Award	Chief Legal Officer	AAward	+300K sh	—	—	300,000
2023-09-29	SPRYARS Pharmaceuticals, Inc.P Purchase	Chief Legal Officer	PPurchase	+46.3K sh	$3.78	+$175K	89,227
2023-09-28	SPRYARS Pharmaceuticals, Inc.P Purchase	Chief Legal Officer	PPurchase	+40K sh	$3.62	+$145K	42,969
2023-01-03	SPRYARS Pharmaceuticals, Inc. · Stock option (right to buy)A Award	Chief Legal Officer	AAward	+700K sh	—	—	700,000
2022-02-18	EVFMEvofem Biosciences, Inc. · Stock option (right to buy)A Award	General Counsel and Secretary	AAward	+300K sh	—	—	300,000
2022-02-18	EVFMEvofem Biosciences, Inc.A Award	General Counsel and Secretary	AAward	+300K sh	—	—	516,422
2021-12-31	EVFMEvofem Biosciences, Inc.D Disposition to Issuer	General Counsel and Secretary	DDisposition to Issuer	−120K sh	—	—	216,422
2021-12-20	EVFMEvofem Biosciences, Inc.P Purchase	General Counsel and Secretary	PPurchase	+25K sh	$0.39	+$9,725	336,422
2021-06-10	EVFMEvofem Biosciences, Inc.P Purchase	General Counsel and Secretary	PPurchase	+10K sh	$1.02	+$10.3K	311,422
2021-05-20	EVFMEvofem Biosciences, Inc.F Tax Payment	General Counsel and Secretary	FTax Payment	−42.1K sh	$0.86	−$36.2K	301,422
2021-02-03	EVFMEvofem Biosciences, Inc. · Stock option (right to buy)A Award	General Counsel and Secretary	AAward	+150K sh	—	—	150,000
2021-02-03	EVFMEvofem Biosciences, Inc.A Award	General Counsel and Secretary	AAward	+200K sh	—	—	343,542
2020-11-17	EVFMEvofem Biosciences, Inc.P Purchase	General Counsel and Secretary	PPurchase	+9,090 sh	$2.20	+$20K	143,542
2020-06-05	EVFMEvofem Biosciences, Inc.F Tax Payment	General Counsel and Secretary	FTax Payment	−31.6K sh	$3.31	−$105K	134,452
2020-05-22	EVFMEvofem Biosciences, Inc.F Tax Payment	General Counsel and Secretary	FTax Payment	−39.5K sh	$4.99	−$197K	166,042
2020-05-06	EVFMEvofem Biosciences, Inc.F Tax Payment	General Counsel and Secretary	FTax Payment	−7,802 sh	$5.24	−$40.9K	205,529
2020-02-05	EVFMEvofem Biosciences, Inc. · Stock option (right to buy)A Award	General Counsel and Secretary	AAward	+100K sh	—	—	100,000
2020-02-05	EVFMEvofem Biosciences, Inc.A Award	General Counsel and Secretary	AAward	+150K sh	—	—	213,331
2019-11-25	EVFMEvofem Biosciences, Inc.F Tax Payment	General Counsel and Secretary	FTax Payment	−7,747 sh	$6.22	−$48.2K	63,331
2019-11-20	EVFMEvofem Biosciences, Inc.F Tax Payment	General Counsel and Secretary	FTax Payment	−7,747 sh	$5.74	−$44.5K	71,078
2019-10-16	EVFMEvofem Biosciences, Inc.F Tax Payment	General Counsel and Secretary	FTax Payment	−18.4K sh	$5.01	−$92.3K	78,825
2019-08-22	EVFMEvofem Biosciences, Inc.F Tax Payment	General Counsel and Secretary	FTax Payment	−1,296 sh	$5.13	−$6,648.48	97,252
2019-06-10	EVFMEvofem Biosciences, Inc.F Tax Payment	General Counsel and Secretary	FTax Payment	−7,777 sh	$6.36	−$49.5K	98,548
2019-04-01	EVFMEvofem Biosciences, Inc.F Tax Payment	General Counsel and Secretary	FTax Payment	−1,298 sh	$3.55	−$4,607.9	106,325
2019-02-25	EVFMEvofem Biosciences, Inc.A Award	General Counsel and Secretary	AAward	+50K sh	—	—	107,623
2018-11-28	EVFMEvofem Biosciences, Inc. · Stock option (right to buy)A Award	General Counsel and Secretary	AAward	+100K sh	—	—	100,000
2018-11-28	EVFMEvofem Biosciences, Inc. · Stock option (right to buy)A Award	General Counsel and Secretary	AAward	0 sh	—	—	100,000
2018-10-16	EVFMEvofem Biosciences, Inc.F Tax Payment	General Counsel and Secretary	FTax Payment	−17.4K sh	$3.78	−$65.7K	57,623
2018-08-21	EVFMEvofem Biosciences, Inc.P Purchase	General Counsel and Secretary	PPurchase	+500 sh	$2.27	+$1,135	75,000
2018-08-20	EVFMEvofem Biosciences, Inc.P Purchase	General Counsel and Secretary	PPurchase	+4,500 sh	$2.20	+$9,900	74,500
2018-07-31	EVFMEvofem Biosciences, Inc. · Stock option (right to buy)A Award	General Counsel and Secretary	AAward	0 sh	—	—	104,500
2018-07-02	EVFMEvofem Biosciences, Inc.A Award	General Counsel and Secretary	AAward	+70K sh	—	—	70,000
2018-03-12	EVFMEvofem Biosciences, Inc. · Stock option (right to buy)A Award	General Counsel and Secretary	AAward	+275K sh	—	—	275,000
2013-10-31	VERENIUM CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	Sr. VP & General Counsel	DDisposition to Issuer	−25K sh	—	—	0
2013-10-31	VERENIUM CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	Sr. VP & General Counsel	DDisposition to Issuer	−20K sh	—	—	0
2013-10-31	VERENIUM CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	Sr. VP & General Counsel	DDisposition to Issuer	−25K sh	—	—	0
2013-10-31	VERENIUM CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	Sr. VP & General Counsel	DDisposition to Issuer	−50K sh	—	—	0
2013-10-31	VERENIUM CORPD Disposition to Issuer	Sr. VP & General Counsel	DDisposition to Issuer	−7,496 sh	$4.00	−$30K	0
2013-08-01	VERENIUM CORPEmployee Stock Option (Right to Buy)A Award	Sr. VP & General Counsel	AAward	+25K sh	—	—	25,000
2012-08-02	VERENIUM CORPEmployee Stock Option (Right to Buy)A Award	Sr. VP & General Counsel	AAward	+20K sh	$4.23	+$84.6K	20,000
2011-08-19	VERENIUM CORPP Purchase	Sr. VP & General Counsel	PPurchase	+7,203 sh	$1.90	+$13.7K	7,496
2011-08-18	VERENIUM CORPP Purchase	Sr. VP & General Counsel	PPurchase	+293 sh	$1.85	+$542.05	293
2011-07-27	VERENIUM CORPEmployee Stock Option (Right to Buy)A Award	Sr. VP & General Counsel	AAward	+50K sh	$1.62	+$81K	50,000
2010-11-09	VERENIUM CORPEmployee Stock Option (Right to Buy)A Award	Sr. VP & General Counsel	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Jun 124
Fitzpatrick Alexander A0001398595-26-000004
SEC(opens sec.gov)
Jan 54
Fitzpatrick Alexander A0001398595-26-000002
SEC(opens sec.gov)
May 224
Fitzpatrick Alexander A0001415889-25-014186
SEC(opens sec.gov)
Jan 34
Fitzpatrick Alexander A0001415889-25-000463
SEC(opens sec.gov)
Jan 44
Fitzpatrick Alexander A0001209191-24-000804
SEC(opens sec.gov)
Oct 24
Fitzpatrick Alexander A0001209191-23-051073
SEC(opens sec.gov)
Jan 54
Fitzpatrick Alexander A0001209191-23-001931
SEC(opens sec.gov)
Feb 234
Fitzpatrick Alexander A0001618835-22-000031
SEC(opens sec.gov)
Jan 44
Fitzpatrick Alexander A0001618835-22-000006
SEC(opens sec.gov)
Dec 204
Fitzpatrick Alexander A0001618835-21-000273
SEC(opens sec.gov)
Jun 104
Fitzpatrick Alexander A0001618835-21-000146
SEC(opens sec.gov)
May 214
Fitzpatrick Alexander A0001618835-21-000137
SEC(opens sec.gov)
Feb 34
Fitzpatrick Alexander A0001618835-21-000009
SEC(opens sec.gov)
Nov 184
Fitzpatrick Alexander A0001618835-20-000246
SEC(opens sec.gov)
Jun 84
Fitzpatrick Alexander A0001618835-20-000185
SEC(opens sec.gov)

Companies

Address

C/O ARS PHARMACEUTICALS, INC. 11682 EL CAMINO REAL, SUITE 300

SAN DIEGO, CA, 92130